Haemonetics HAE Corporate — Restructuring related costs
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept hae:RestructuringRelatedCosts.
The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's corporate — restructuring related costs.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's corporate — restructuring related costs?
- Haemonetics (HAE) reported corporate — restructuring related costs of $37K in Q4 2025.
- How has Haemonetics's corporate — restructuring related costs changed year-over-year?
- Haemonetics's corporate — restructuring related costs decreased by 97.5% year-over-year, from $1.47M to $37K.
- What does corporate — restructuring related costs mean?
- This metric captures the expenses associated with organizational realignment, including severance payments, facility closures, and integration costs related to strategic business shifts. It highlights the financial impact of management's efforts to optimize the cost structure and improve long-term operational efficiency. Monitoring these costs helps investors evaluate the scale of transformation initiatives and the potential for future margin expansion.